deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02451995

Effectiveness of Ripple Mapping in Atrial Tachycardia Ablation (RIPPLE-AT)

A Prospective Multi-centre Study of Effectiveness of Ripple Mapping for Atrial Tachycardia Ablation

Sponsor: Imperial College London

Updated 9 times since 2017 Last updated: Jul 24, 2019 Started: Jun 30, 2015 Primary completion: May 31, 2018 Completion: May 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02451995, this NA trial focuses on Atrial Tachycardia and remains completed. Sponsored by Imperial College London, it has been updated 9 times since 2015, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotRecruiting~Sep 2018 – ~Aug 2019 · 11 months · monthly snapshotCompleted~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2023 — Jul 2024 [monthly]

    Completed NA

  4. Dec 2022 — Jan 2023 [monthly]

    Completed NA

  5. Jan 2021 — Dec 2022 [monthly]

    Completed NA

Show 4 earlier versions
  1. Aug 2019 — Jan 2021 [monthly]

    Completed NA

  2. Sep 2018 — Aug 2019 [monthly]

    Completed NA

    Status: RecruitingCompleted

  3. Jun 2018 — Sep 2018 [monthly]

    Recruiting NA

  4. Jan 2017 — Jun 2018 [monthly]

    Recruiting NA

    First recorded

Jun 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Imperial College London
Data source: Imperial College London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations